𝔖 Bobbio Scriptorium
✦   LIBER   ✦

1027 Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of signal transducers and activators of transcription 3

✍ Scribed by K.F. Chen; T.H. Liu; W.T. Tai; P.J. Chen; A.L. Cheng


Book ID
119600081
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
47 KB
Volume
7
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Honokiol inhibits signal transducer and
✍ Peramaiyan Rajendran; Feng Li; Muthu K. Shanmugam; Shireen Vali; Taher Abbasi; S πŸ“‚ Article πŸ“… 2012 πŸ› John Wiley and Sons 🌐 English βš– 648 KB

## Abstract The activation of signal transducers and activators of transcription 3 (STAT3) has been closely linked with the proliferation, survival, invasion, and angiogenesis of hepatocellular carcinoma (HCC) and represents an attractive target for therapy. In the present report, we investigated w

Parthenolide sensitizes hepatocellular c
✍ Daniela Carlisi; Antonella D'Anneo; Liliana Angileri; Marianna Lauricella; Sonia πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 932 KB

## Abstract This article shows that HepG2, Hep3B, and SK‐Hep1 cells, three lines of human hepatocellular carcinoma (HCC) cells, are resistant to apoptosis induced by tumor necrosis factor‐related apoptosis‐inducing ligand (TRAIL). Parthenolide, a sesquiterpene lactone found in European feverfew, ha